Stocks Health care PULM

NASDAQ · Health care

Pulmatrix, Inc. (PULM)

It posted a net loss of $4M. At June 30, 2026 it held $2.2M in cash. Its latest periodic report to the SEC is the quarterly report (10-Q) filed on August 13, 2026.

Watch PULM in 60 seconds

Follow PULM

Free, no password. An email when PULM files with the SEC.

Key facts about Pulmatrix, Inc.

Net worth

Pulmatrix, Inc. has a market value (market cap) of $4.9M at the latest share price, and shareholders' equity of $2.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Revenue and profit

In fiscal 2024 revenue was $7.8M (+7.0% year on year), with a net loss of $9.6M.

Cash flow

In fiscal 2025 operations used $5.4M of cash.

Latest report

The latest periodic report (quarterly report, 10-Q) was filed with the SEC on August 13, 2026 and covers the period to June 30, 2026. Open on SEC EDGAR

Next earnings report

Pulmatrix, Inc.'s next report was expected around October 15, 2026 and is not on file with the SEC yet.

What Pulmatrix, Inc. does

Pulmatrix, Inc. is registered with the SEC under industry code SIC 2834 (Pharmaceutical Preparations). Its shares trade on NASDAQ under the ticker PULM.

Revenue and profit by year

Fiscal years as reported in annual reports. Amounts in USD.

Key figures

Earnings: every quarter and the next report date

Full financial statements: income, balance sheet and cash flow

Latest SEC filings

What Pulmatrix, Inc. has filed recently, newest first. Each links to the original document on SEC EDGAR.

1. October 5, 2026
   Annual report to shareholders ARS
2. October 5, 2026
   Shelf registration to sell securities (amended) S-3/A
3. September 25, 2026
   Merger proxy statement DEFM14A
4. September 23, 2026
   Merger registration (amended) S-4/A
5. September 22, 2026
   Form 425 filing 425
6. September 17, 2026
   Merger registration (amended) S-4/A
7. September 4, 2026
   Merger registration (amended) S-4/A
8. August 13, 2026
   Quarterly report 10-Q · period to June 30, 2026Diluted EPS -$0.29 versus -$0.42.
9. August 13, 2026
   Quarterly results 8-K
10. August 7, 2026
    Shelf registration to sell securities (amended) S-3/A

Recent insider filings (Forms 3, 4 and 144): 7, the latest on January 30, 2023. Insider transactions on SEC

Insider trades

What the people running Pulmatrix, Inc. did with its shares, from the Form 4 filings they must send the SEC within two business days.

No insider trades were reported in the last 90 days.

All insider filings on SEC.gov · Where insiders are buying across the market

Who owns PULM

Three views from three kinds of SEC filings, each with its own date. They overlap and are not added up.

5% holders

Anyone who owns more than 5% of a class of shares must say so on Schedule 13D (if they may seek to influence the company) or 13G (a passive holder). The latest filing of each holder is shown: 13G filings of the last 2 years, 13D of the last 3.

Largest institutional holders

No Form 13F positions imported for this company yet.

Insiders

Reported holdings of insiders who filed a Form 4 in the last 12 months: the shares each one held after their latest reported transaction. This is not the total held by all insiders.

No insider reported holdings on a Form 4 in the last 12 months.

Schedule 13D/13G filings on SEC.gov

All filings on SEC EDGAR

Questions about PULM

What does Pulmatrix, Inc. do?

Pulmatrix, Inc. is a company in the Health care sector, listed on NASDAQ as PULM. Its shares trade on NASDAQ under the ticker PULM.

What is Pulmatrix, Inc.'s net worth?

Pulmatrix, Inc. has a market value (market cap) of $4.9M at the latest share price, and shareholders' equity of $2.6M on its balance sheet at June 30, 2026. A company's "net worth" usually means one of these: what the market pays for all its shares, or its assets minus its liabilities.

Is Pulmatrix, Inc. profitable?

No. Over the twelve months to June 30, 2026 it reported a net loss of $4M.

When did Pulmatrix, Inc. last report?

Its most recent periodic report is the quarterly report (10-Q) filed on August 13, 2026. It covers the period to June 30, 2026. Its newest filing of any kind is the annual report to shareholders from October 5, 2026.

When is Pulmatrix, Inc.'s next earnings report?

Pulmatrix, Inc.'s next report was expected around October 15, 2026 and is not on file with the SEC yet.

Similar companies

Compare PULM with

Compare PULM with any company

Follow PULM

Get an email when Pulmatrix, Inc. files with the SEC: results, executive changes, material agreements and annual reports.

Follow PULM

Free, no password. An email when PULM files with the SEC.

Where the numbers come from

Financial figures are the values Pulmatrix, Inc. tagged in its own SEC filings (XBRL), taken from the latest filing for each period, so restatements replace older figures. Revenue, profit and cash flow are for full fiscal years unless marked as the last twelve months, which is the sum of the four most recent quarters. Where a company reports only the full year, the fourth quarter is the year minus the first three.

Prices are delayed end-of-day market data in the listing currency, and market cap moves with the price. P/E is shown only when earnings per share are positive. Nothing here is investment advice.